Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City - 11/10/22
Abstract |
Background |
The impact of the COVID-19 mammography screening hiatus as well as of post-hiatus efforts promoting restoration of elective healthcare on breast cancer detection patterns and stage distribution is unknown.
Methods |
Newly diagnosed breast cancer patients (2019–2021) at the New York Presbyterian (NYP) Hospital Network were analyzed. Chi-square and student's t-test compared characteristics of patients presenting before and after the screening hiatus.
Results |
A total of 2137 patients were analyzed. Frequency of screen-detected and early-stage breast cancer declined post-hiatus (59.7%), but returned to baseline (69.3%). Frequency of screen-detected breast cancer was lowest for African American (AA) (57.5%) and Medicaid patients pre-hiatus (57.2%), and this disparity was reduced post-hiatus (65.3% for AA and 63.2% for Medicaid).
Conclusions |
The return to baseline levels of screen-detected cancer, particularly among AA and Medicaid patients suggest that large-scale breast health education campaigns may be effective in resuming screening practices and in mitigating disparities.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Fewer screen-detected breast cancers were diagnosed after the COVID-19 screening hiatus. |
• | Return to baseline levels was observed by mid-2021. |
• | Racial disparities in screen-detection were seen prior to the pandemic. |
• | Screen-detection disparities were mitigated post-hiatus. |
Keywords : Breast cancer, Mammography, Healthcare disparities, COVID-19, Screening
Plan
Vol 224 - N° 4
P. 1039-1045 - octobre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.